Lactobacillus rhamnosus
EVIDENCE: WEAKAlso sold as: L. rhamnosus, Lacticaseibacillus rhamnosus, L. rhamnosus GG, LGG, SD11, SP1, GR-1
Dental studies of L. rhamnosus primarily used specific live strains in milk consumed by children over several months. Adult evidence is limited. These findings do not establish effects from unnamed strains or inactivated postbiotic preparations.
Compiled by iSupplementReviews editorial team ·Updated 2026-10-06 · 6 sources
- Type
- Probiotic — digestive and immune species
- Studied dose
- ~10⁷–10⁹ CFU/day live bacteria in milk/yogurt, daily for months (pediatric caries trials)
- Best form
- Named live strain with CFU count — GG, SD11, and SP1 are the caries-studied strains; 'L. rhamnosus' alone is a species name, not a studied organism
- Our rating
- WEAK — Mostly small, animal, or traditional evidence
What is Lactobacillus rhamnosus?
L. rhamnosus, now Lacticaseibacillus rhamnosus, is a widely researched probiotic species. GG has substantial pediatric digestive research. Other named strains include GR-1, SD11, and SP1, with distinct studies; their results are not interchangeable.
Other names and forms it’s sold as
- LGG: the main ingredient strain with the deepest clinical record
- GR-1: the women’s-health strain (vaginal/UTI research)
- SD11, SP1: the caries-studied strains (Thai and Chilean milk studies)
- Generic “L. rhamnosus”: species listing; the strain could be anything
- Postbiotic/inactivated forms: dead cells or metabolites; no human dental trials
What is it claimed to do?
In dental products: inhibit gum-disease bacteria, create a “tooth shield,” produce antimicrobials, protect against bone loss. The provenance: pediatric caries trials with specific live strains, plus the species’ general immune reputation.
What does the research show?
| Claim | Evidence | Dose studied | Verdict |
|---|---|---|---|
| Reduced caries risk in children | Näse 2001 trial: 594 children, LGG milk 7 months → caries risk ~halved (OR 0.56), mutans strep ↓; SD11 and SP1 milk trials echo | ~10⁷–10⁸+ CFU/day, months | Supported (children, named strains, milk delivery) |
| Lower mutans streptococci | Multiple pediatric trials, consistent direction | 10⁷ CFU/day+ | Supported (children) |
| Adult gum/breath benefit | No direct human trials | — | Can’t confirm |
| “Tooth shield” / gum-disease protection | Mechanistic speculation | — | Can’t confirm |
| Same effects from postbiotic form | No human oral trials | — | Unproven |
| GI/antibiotic-associated diarrhea | Meta-analyzed, strongest in children | 10¹⁰–10¹¹ CFU | Supported (GG) — but that’s a different product |
The strain problem, stated plainly
“L. rhamnosus” on a label is like “a dog” on a missing-pet poster: GG, GR-1, SD11, and SP1 are different strains with different evidence, and the pediatric caries findings attach to named strains delivered daily in milk. A formula that won’t name the strain, won’t give a CFU count, and calls the organism a “postbiotic” (i.e., dead) is three steps removed from the trial product.
What dose was studied?
| Goal | Dose | Form/route | Duration |
|---|---|---|---|
| Caries risk (children) | LGG in milk with meals | milk, 5 days/week | 7 months |
| Mutans strep ↓ / caries progression | SD11 ~10⁷ CFU/g powder | milk powder daily | 3 months |
| Caries increment (high-risk children) | SP1 ~10⁷ CFU/mL | milk, weekdays | 10 months |
| Plaque index / salivary pH | LGG yogurt 200 mL | daily | 14 days |
Side effects
Among the safest studied organisms: decades of pediatric trials with clean records. Rare class-level caution for live probiotics in the severely immunocompromised.
Drug interactions
None documented at supplement doses; antibiotics kill the live organism (space dosing).
Who should not take it?
Severely immunocompromised or critically ill patients (live-organism caution). Otherwise broadly tolerated; milk-delivered studies mean dairy delivery, which tablet forms avoid but at the cost of losing the studied vehicle.
What the authorities say
No authority has endorsed any probiotic strain for caries prevention or gum health; LGG holds no drug approvals. It’s a supplement organism with strong trial literature for a few specific uses, oral health not among them beyond the pediatric caries corner.
What to know about L. rhamnosus
L. rhamnosus dental evidence is mainly pediatric and strain-specific. Studies using live bacteria in milk over months do not establish results from an adult tablet or inactivated postbiotic. Its broader digestive reputation does not fill that gap.
Frequently asked questions about Lactobacillus rhamnosus
Does L. rhamnosus prevent cavities?
In children, plausibly. The landmark Näse 2001 trial gave 594 daycare children milk containing LGG for 7 months and found caries risk cut roughly in half (OR 0.56), with lower mutans streptococci counts. Two later trials (SD11 in Thailand, SP1 in Chile) also found reduced salivary mutans strep or caries progression. All pediatric, all live bacteria in daily milk; whether the same holds for adults or tablets is untested.
Does it help adult gums or breath?
No meaningful adult human evidence. The oral trials are pediatric caries studies; gum inflammation and breath outcomes in adults haven't been properly studied for this species.
What is L. rhamnosus proven for?
Gut outcomes. LGG is among the most-studied probiotic strains ever, with meta-analyzed evidence for antibiotic-associated diarrhea prevention in children and some acute stomach-bug benefit. Its immune reputation is what dental products borrow.
Is 'postbiotic' L. rhamnosus the same as the studied versions?
No published human oral trial has used a dead/inactivated rhamnosus preparation. The pediatric caries findings belong to live organisms delivered daily in milk over months; a heat-killed cell or metabolite fraction is a different, unproven product.
Is L. rhamnosus safe?
Extensively safe in healthy people across decades of trials; the standard live-probiotic caution applies to severely immunocompromised patients (rare bloodstream-infection reports across the lactobacillus class). GR-1 strain variants are common in women's-health formulas.
References
- [1]Long-term LGG milk consumption and dental caries/caries risk in children — RCT (Caries Res 2001)
- [2]L. rhamnosus SD11 supplementation and caries prevention in young children — RCT (Khon Kaen Dent J 2025)
- [3]Probiotic (L. rhamnosus SP1) milk vs standard milk for caries increment in preschoolers — triple-blind RCT (J Dent Res 2016)
- [4]LGG-enriched yogurt and dental plaque/salivary pH in children (Srp Arh Celok Lek 2011)
- [5]Probiotic L. rhamnosus GG / B. longum milk for cariogenic markers — registered trial (NCT03078179)
- [6]Postbiotics and dental caries — systematic review, 3 human trials among 21 studies (Caries Res 2025)
Products we reviewed containing Lactobacillus rhamnosus
Based on recorded labels or seller-described formulas. Inclusion does not establish a match to the strains, preparations or amounts studied here; check each review's disclosure limits.